Ectin Research AB (XSAT:ECTIN B) ROE % Adjusted to Book Value : -69.97% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB ROE % Adjusted to Book Value?

Ectin Research AB's ROE % for the quarter that ended in Mar. 2024 was -301.56%. Ectin Research AB's PB Ratio for the quarter that ended in Mar. 2024 was 4.31. Ectin Research AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -69.97%.

Ectin Research AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Ectin Research AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB ROE % Adjusted to Book Value Chart

Ectin Research AB Annual Data

Trend

Aug19

Aug20

Dec22

Dec23

ROE % Adjusted to Book Value

-177.80

-143.05

Ectin Research AB Quarterly Data
	Aug19	Aug20	Mar21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-94.29	-82.22	-141.92	-485.00	-69.97

Competitive Comparison of Ectin Research AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Ectin Research AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ectin Research AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's ROE % Adjusted to Book Value falls into.

Ectin Research AB ROE % Adjusted to Book Value Calculation

Ectin Research AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-134.47%	/	0.94
	=	-143.05%

Ectin Research AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-301.56%	/	4.31
	=	-69.97%

Ectin Research AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB (XSAT:ECTIN B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.ectinresearch.com

Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines